EUVIMEDEUVIMED entdecken
Crossref

Dihydromyricetin protects sevoflurane‐induced mitochondrial dysfunction in HT22 hippocampal cells

Xinyan Wang, Haoyi Li, Dongchao Qu

Clinical and Experimental Pharmacology and Physiology · 2024

DOI: 10.1111/1440-1681.13912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2024. Verfasst von Xinyan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Flavonols, Mitochondria, Hippocampus, Sevoflurane. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sevoflurane (Sev) is a commonly used inhalation anaesthetic that has been shown to cause hippocampus dysfunction through multiple underlying molecular processes, including mitochondrial malfunction, oxidative stress and inflammation. Dihydromyricetin (DHM) is a 2,3‐dihydroflavonoid with various biological properties, such as anti‐inflammation and anti‐oxidative stress. The purpose of this study was to investigate the effect of DHM on Sev‐induced neuronal dysfunction. HT22 cells were incubated with 10, 20 and 30 μM of DHM for 24 h, and then stimulated with 4% Sev for 6 h. The effects and mechanism of DHM on inflammation, oxidative stress and mitochondrial dysfunction were explored in Sev‐induced HT22 cells by Cell Counting Kit‐8, flow cytometry, enzyme‐linked immunosorbent assay, reverse transcription‐quantitative polymerase chain reaction, colorimetric detections, detection of the level of reactive oxygen species (ROS), mitochondrial ROS and mitochondrial membrane potential (MMP), immunofluorescence and western blotting. Our results showed that DHM increased Sev‐induced cell viability of HT22 cells. Pretreatment with DHM attenuated apoptosis, inflammation, oxidative stress and mitochondrial dysfunction in Sev‐elicited HT22 cells by remedying the abnormality of the indicators involved in these progresses, including apoptosis rate, the cleaved‐caspase 3 expression, as well as the level of tumour necrosis factor α, interleukin (IL)‐1β, IL‐6, malondialdehyde, superoxide dismutase, catalase, ROS, mitochondrial ROS and MMP. Mechanically, pretreatment with DHM restored the Sev‐induced the expression of SIRT1/FOXO3a pathway in HT22 cells. Blocking of SIRT1 counteracted the mitigatory effect of DHM on apoptosis, inflammation, oxidative stress and mitochondrial dysfunction in Sev‐elicited HT22 cells. Collectively, pretreatment with DHM improved inflammation, oxidative stress and mitochondrial dysfunction via SIRT1/FOXO3a pathway in Sev‐induced HT22 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsMitochondriaHippocampusSevofluraneOxidative StressApoptosisAnimalsMiceCell LineMembrane Potential, MitochondrialReactive Oxygen SpeciesCell SurvivalSirtuin 1Neuroprotective Agents

Stichwörter der Autor:innen

SIRT1/FOXO3adihydromyricetininflammationmitochondrial dysfunctionneuronsoxidative stresssevoflurane

Substanzen

FlavonolsdihydromyricetinSevofluraneReactive Oxygen SpeciesSirtuin 1Neuroprotective Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.

Zitieren

APA

Wang, X., Li, H., & Qu, D. (2024). Dihydromyricetin protects sevoflurane‐induced mitochondrial dysfunction in HT22 hippocampal cells. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.13912

Vancouver

Wang X, Li H, Qu D. Dihydromyricetin protects sevoflurane‐induced mitochondrial dysfunction in HT22 hippocampal cells. Clinical and Experimental Pharmacology and Physiology. 2024. doi:10.1111/1440-1681.13912

BibTeX
@article{Wang2024,
  author = {Wang, Xinyan and Li, Haoyi and Qu, Dongchao},
  title = {Dihydromyricetin protects sevoflurane‐induced mitochondrial dysfunction in HT22 hippocampal cells},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2024},
  doi = {10.1111/1440-1681.13912}
}
Kostenlos starten →